Concepedia

Daniel W. Norbeck

DW

Statistics

Publications

51

Citations

6K

H-Index

33

Active since

1985

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

National Cancer Institute

Daniel W. Norbeck is an author at Abbott Fund specializing in enzyme inhibition, medicinal chemistry, and antiviral pharmacology.

Publications per year

1985–2005

51

Publications

51

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

Akhteruzzaman Molla, Marina Korneyeva, Qing Gao et al. · Nature Medicine · 1996 · 768 citations

Life Sciences, Genetics, Molecular Biology +14

Design, Activity, and 2.8 Å Crystal Structure of a <i>C</i> <sub>2</sub> Symmetric Inhibitor Complexed to HIV-1 Protease

John W. Erickson, David J. Neidhart, John H. VanDrie et al. · Science · 1990 · 528 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 470 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir

Dale J. Kempf, Kennan C. Marsh, Gondi Kumar et al. · Antimicrobial Agents and Chemotherapy · 1997 · 420 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Application of the Swern oxidation to the manipulation of highly reactive carbonyl compounds

Robert E. Ireland, Daniel W. Norbeck · The Journal of Organic Chemistry · 1985 · 265 citations

Natural Sciences, Chemistry, Analytical Chemistry +10

1–5 of 51